Non-Steroidal Anti-Inflammatory Drug Use, Hormone Receptor Status, and Breast Cancer-Specific Mortality in the Carolina Breast Cancer Study

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-014-3099-z
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Genetic Variants in COX-2, Non-Steroidal Anti-Inflammatory Drugs, and Breast Cancer Risk: The Western New York Exposures and Breast Cancer (WEB) Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Breast Cancer Risk: Differences by Molecular Subtype

Cancer Causes and Control
Cancer ResearchOncology
2011English

Prediagnostic Use of Hormone Therapy and Mortality After Breast Cancer

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Non-Steroidal Anti-Inflammatory Drug Use and Colorectal Polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

American Journal of Gastroenterology
HepatologyGastroenterology
2010English

Folate Intake and Risk of Breast Cancer Characterized by Hormone Receptor Status

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2005English

Non-Steroidal Anti-Inflammatory Drugs and Small Cell Lung Cancer Risk in the VITAL Study

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2012English

Genome-Wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence

Cancer Research
Cancer ResearchOncology
2011English

Menopausal Hormone Therapy and 20-Year Breast Cancer Mortality

The Lancet
Medicine
2019English

Mammographic Density and Hormone Receptor Expression in Breast Cancer: The Multiethnic Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy